Dr. Russell Chan is the co-founder and CEO of E-SENSE Innovation & Technology. He obtained his B.Eng. in biomedical engineering and Ph.D. in electrical and electronic engineering from The University of Hong Kong (HKU). He was a post-doctoral research fellow at Stanford University in Neurology and Neurological Sciences, and New York University in Neuroscience, Tech4Health, and Ophthalmology. Previously CTO of a Forbes Asia 100 to Watch startup, he was named REVIVE 2023 CTO of the Year and received the HKEST award in 2022. Under his leadership, E-SENSE has received the Tech Impact Company of the Year, and Gold Medal with Jury Congratulations at the 2025 Geneva Inventions Exhibition. Dr. Chan is an elected Junior Fellow of International Society of Magnetic Resonance in Medicine (ISMRM), a prestigious and highly selective award for young scientists from the leading global MRI society. He is the Chair of the Young Member Section at the Hong Kong Academy of Engineering (HKAE). He is the ex-co member and R&D focus group lead of the Hong Kong Institute of Engineers (HKIE) Biomedical Division. His focus is the research, development, application, and commercialization of state-of-the-art multi-modal and multi-scale biomedical imaging devices to improve quality of life.